Ligand validation:6TI1

GOL: GLYCEROL

GOL is a Ligand Of Interest in 6TI1 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6TI1_GOL_A_501	90%	89%	0.09	0.971	0.33	0.31	-	-	0	0	100%	1
6TI4_GOL_A_501	85%	86%	0.114	0.979	0.23	0.49	-	-	0	0	100%	1
4WXB_GOL_B_504	83%	68%	0.096	0.954	0.45	0.77	-	-	0	0	100%	1
6TI3_GOL_B_501	77%	58%	0.13	0.969	0.98	0.66	-	-	0	0	100%	1
6YRW_GOL_B_503	76%	71%	0.106	0.943	0.32	0.78	-	-	0	0	100%	1
4WXF_GOL_A_503	51%	62%	0.174	0.928	0.32	1.13	-	-	0	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.